Total Payments
$504,002
2024 Payments
$39,058
Companies
38
Transactions
1,113
Medicare Patients
5,359
Medicare Billing
$296,858
Payment Breakdown by Category
Other$443,890 (88.1%)
Consulting$25,629 (5.1%)
Food & Beverage$17,625 (3.5%)
Travel$16,440 (3.3%)
Education$418.22 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $443,890 | 266 | 88.1% |
| Consulting Fee | $25,629 | 16 | 5.1% |
| Food and Beverage | $17,625 | 695 | 3.5% |
| Travel and Lodging | $16,440 | 123 | 3.3% |
| Education | $418.22 | 13 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $149,031 | 221 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $123,263 | 204 | $0 (2024) |
| PFIZER INC. | $75,678 | 133 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $51,724 | 94 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36,897 | 72 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $20,240 | 26 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $19,780 | 45 | $0 (2022) |
| Lilly USA, LLC | $15,558 | 16 | $0 (2023) |
| Johnson & Johnson Health Care Systems Inc. | $4,020 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $1,276 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,058 | 87 | Kiniksa Pharmaceuticals International, plc ($20,116) |
| 2023 | $54,017 | 101 | Actelion Pharmaceuticals US, Inc. ($23,080) |
| 2022 | $40,042 | 81 | Actelion Pharmaceuticals US, Inc. ($19,670) |
| 2021 | $44,141 | 100 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16,933) |
| 2020 | $53,071 | 98 | AstraZeneca Pharmaceuticals LP ($21,231) |
| 2019 | $61,486 | 181 | PFIZER INC. ($21,864) |
| 2018 | $100,050 | 231 | E.R. Squibb & Sons, L.L.C. ($46,230) |
| 2017 | $112,136 | 234 | E.R. Squibb & Sons, L.L.C. ($63,983) |
All Payment Transactions
1,113 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Rheumatology | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $126.21 | General |
| Category: Rheumatology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $107.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Travel and Lodging | In-kind items and services | $18.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Rheumatology | ||||||
| 12/02/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | Cash or cash equivalent | $20.10 | General |
| Category: Rheumatology | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $49.02 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 11/21/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $30.11 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: Cardiovascular | ||||||
| 10/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $69.30 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,090.00 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $97.02 | General |
| Category: Rheumatology | ||||||
| 10/16/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Cardiology | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Rheumatology | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $545.00 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $119.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,176 | 1,315 | $142,713 | $68,057 |
| 2022 | 21 | 1,182 | 1,356 | $155,488 | $68,209 |
| 2021 | 23 | 1,485 | 1,644 | $170,951 | $83,875 |
| 2020 | 23 | 1,516 | 1,685 | $174,849 | $76,717 |
Total Patients
5,359
Total Services
6,000
Medicare Billing
$296,858
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 247 | $40,071 | $19,972 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 92 | 133 | $13,879 | $9,095 | 65.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 159 | 159 | $21,045 | $8,046 | 38.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $7,237 | $3,346 | 46.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 58 | 58 | $8,464 | $3,184 | 37.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 49 | $5,207 | $3,045 | 58.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 30 | $4,694 | $2,828 | 60.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $5,154 | $2,623 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 48 | $5,953 | $2,149 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $2,680 | $1,788 | 66.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $3,162 | $1,739 | 55.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 61 | 61 | $4,493 | $1,688 | 37.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 20 | 20 | $2,532 | $1,262 | 49.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 24 | 24 | $3,170 | $1,254 | 39.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 44 | 44 | $3,185 | $1,116 | 35.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 62 | 63 | $2,583 | $973.39 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 18 | $1,386 | $827.52 | 59.7% |
| 93922 | Ultrasound study of arm and leg arteries | Facility | 2023 | 81 | 81 | $1,944 | $734.16 | 37.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 62 | 63 | $1,701 | $648.83 | 38.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 21 | 21 | $1,008 | $407.19 | 40.4% |
| 76706 | Ultrasound scan of abdominal aorta | Facility | 2023 | 15 | 15 | $769.00 | $389.25 | 50.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 54 | 58 | $846.00 | $341.92 | 40.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Facility | 2023 | 11 | 12 | $888.00 | $330.33 | 37.2% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Facility | 2023 | 13 | 13 | $572.00 | $233.09 | 40.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 15 | 15 | $90.00 | $35.85 | 39.8% |
About Dr. Chad Link, DO
Dr. Chad Link, DO is a Cardiovascular Disease healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750504585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chad Link, DO has received a total of $504,002 in payments from pharmaceutical and medical device companies, with $39,058 received in 2024. These payments were reported across 1,113 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($443,890).
As a Medicare-enrolled provider, Link has provided services to 5,359 Medicare beneficiaries, totaling 6,000 services with total Medicare billing of $296,858. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Lansing, MI
- Active Since 04/10/2007
- Last Updated 09/20/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1750504585
Products in Payments
- ELIQUIS (Drug) $181,321
- UPTRAVI (Drug) $72,712
- JARDIANCE (Drug) $52,289
- FARXIGA (Drug) $48,897
- Arcalyst (Drug) $20,228
- VYNDAQEL (Drug) $10,397
- OPSUMIT (Drug) $9,346
- MULTAQ (Drug) $7,211
- NO PRODUCT DISCUSSED (Drug) $4,651
- DISEASE STATE (Drug) $3,480
- OPSUMIT MACITENTAN (Drug) $3,290
- CHANTIX (Drug) $3,211
- PRALUENT (Drug) $2,533
- LOKELMA (Drug) $2,426
- MK-1242 (Drug) $1,185
- ENTRESTO (Drug) $842.96
- XARELTO (Drug) $601.46
- Repatha (Biological) $347.88
- Impella (Device) $323.50
- WATCHMAN Access System (Device) $296.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lansing
Dr. David Strobl, Do, DO
Cardiovascular Disease — Payments: $692,161
Cardiovascular Disease $692,161
Dr. Milind Karve, Md, MD
Cardiovascular Disease — Payments: $82,678
Cardiovascular Disease $82,678
Robert Gumbita, Do, DO
Cardiovascular Disease — Payments: $52,495
Cardiovascular Disease $52,495
Dr. Peter Burke, Md, MD
Cardiovascular Disease — Payments: $40,258
Cardiovascular Disease $40,258
Dr. Mohammed Qintar, M.d, M.D
Cardiovascular Disease — Payments: $34,799
Cardiovascular Disease $34,799
Dr. Nam Cho, Do, DO
Cardiovascular Disease — Payments: $22,532
Cardiovascular Disease $22,532